NCT00059865: Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
|
|
| Completed | 1/2 | 68 | US | gemcitabine hydrochloride, pemetrexed disodium | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer | 02/07 | 02/08 | | |
